CVE-2024-10035
Bg-tek Coslat command injection
- Published4 Nov 2024
Description
Improper Control of Generation of Code ('Code Injection'), Improper Neutralization of Special Elements used in a Command ('Command Injection'), Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in BG-TEK Informatics Security Technologies CoslatV3 allows Command Injection, Privilege Escalation. This issue affects CoslatV3: through 3.1069. NOTE: The vendor was contacted and it was learned that the product is not supported.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2024-10035 being actively exploited?
CVE-2024-10035 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.85%.
How severe is CVE-2024-10035?
CVE-2024-10035 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 0.85% probability of exploitation.
Which products are affected by CVE-2024-10035?
Affected products include Bg-tek Coslat.
How do I fix CVE-2024-10035?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2024-10035 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.